🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
This study is designed to assess the impact of 13-valent Pneumococcal Conju...
Status
Completed
Location
Pfizer Investigational Sites (7)
Start Date
2007-12
Trial ID
NCT00508742
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-06
Trial ID
NCT00689351
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00373958
Treatments Being Tested
The purpose of this study will be to analyze 13-valent pneumococcal vaccine...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00676091
The purpose of this study will be to evaluate safety, tolerability and immu...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00444457
Treatments Being Tested
This study is primarily designed to evaluate the IgG immune responses to th...
Status
Completed
Location
Jiangsu Province Guanyun County Center for Disease prevention and Control
Start Date
2012-09
Trial ID
NCT01692886
Subjects will be randomly assigned to 1 of 2 groups to receive the followin...
Status
Completed
Location
Tsubaki Children's Clinic
Start Date
2010-11
Trial ID
NCT01250756
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2008-06-05
Trial ID
NCT00688870
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00384059
Treatments Being Tested